In a rough day for PARP inhibitors in ovarian cancer, GSK’s Zejula didn’t deliver a life extension benefit in the final ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...

The College of Natural Sciences welcomed more than a dozen new tenured and tenure-track faculty members in 2024.

High-dose vitamin D added to chemotherapy failed to provide a benefit in patients with metastatic colorectal cancer in the ...

European stocks closed higher on Tuesday amid optimism the Federal Reserve will announce an interest-rate cut on Wednesday. Investors ...

Although immunotherapy is beneficial in some gynecological cancers, it is not for all patients, added Isabelle Ray-Coquard, MD, PhD, with the Cancer Research Center of Lyon, Lyon, France ... Eisai, ...

GIBF2 to invest US$ 6m in BioVersys ; BV100 Phase 1 study in China expected to start in 1H 2025 in preparation for a global ...

However, the analysts said: “Given our own forecast that CPI inflation will rise back to 2.9pc by January next year (perhaps ...

A Bloomberg News report that some of Ukraine's allies are starting to talk about a negotiated ceasefire put a dampener on the ...

Europe can become more competitive when it harnesses the innovative potential of pharmaceutical companies. The Polish ...